Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2000 Jan;7(1):40-4.
doi: 10.1128/CDLI.7.1.40-44.2000.

Antibody responses to antigenic sites 1 and 3 of serotype 3 poliovirus after vaccination with oral live attenuated or inactivated poliovirus vaccine and after natural exposure

Affiliations
Comparative Study

Antibody responses to antigenic sites 1 and 3 of serotype 3 poliovirus after vaccination with oral live attenuated or inactivated poliovirus vaccine and after natural exposure

T Herremans et al. Clin Diagn Lab Immunol. 2000 Jan.

Abstract

Three important antigenic sites involved in virus neutralization on polioviruses in mouse experiments have been identified. These sites are located at the surface of the virion and have been designated antigenic sites 1, 2, and 3. In mice, the antibody response to antigenic site 1 of serotype 3 poliovirus is considered to be immunodominant, but little is known about the immunogenicity of these sites in humans. In the present study, we developed inhibition enzyme-linked immunosorbent assays specific for antigenic sites 1 and 3 to measure antibody responses to these sites in fully vaccinated inactivated poliovirus vaccine (IPV) (n = 63) and oral live attenuated poliovirus vaccine (OPV) (n = 63) recipients and in naturally infected persons (n = 25). Similar levels of antibodies to site 1 in IPV and OPV vaccinees were detected. However, significantly more OPV recipients (88.7%) had detectable antibodies to antigenic site 3 (P < 0.01) than did IPV-vaccinated persons (63. 1%). After an IPV booster vaccination, both previously IPV- and OPV-vaccinated persons responded with a significant increase in antibodies to sites 1 and 3 (P < 0.01). We conclude that the immune response to serotype 3 poliovirus in humans consists of both site 1- and site 3-specific antibodies and that these responses can be induced by either OPV or recent IPV vaccination.

PubMed Disclaimer

Figures

FIG. 1
FIG. 1
Antigenic site 1- and site 3-specific antibody titers in patients with paralytic poliomyelitis (n = 25) and in IPV (n = 63)- and OPV (n = 63)- vaccinated blood donors. Results are expressed as log2 titers. Horizontal lines indicate median values. ∗, P < 0.01; NS, not significant.
FIG. 2
FIG. 2
Antigenic site 1- and site 3-specific responses after IPV booster vaccination of previously IPV (n = 11)- and OPV (n = 10)-vaccinated persons. Results are expressed as log2 titers. Horizontal lines indicate median values. ∗, P < 0.01; NS, not significant.

Similar articles

Cited by

References

    1. Cello J, Strannegrad O, Svennerholm B. A study of the cellular immune response to enteroviruses in humans: identification of cross-reactive T cell epitopes on the structural proteins of enteroviruses. J Gen Virol. 1996;77:2097–2108. - PubMed
    1. Chaplin H, Cohen S, Press E M. Preparation and properties of the peptide chains of normal human 19 s γ-globulin (IgM) Biochem J. 1965;95:256–261. - PMC - PubMed
    1. Conyn-Spaendonck M A E, Oostvogel P M, van Loon A M, van Wijngaarden J K, Kromhout D. Circulation of poliovirus during the poliomyelitis outbreak in The Netherlands in 1992–1993. Am J Epidemiol. 1996;143:929–934. - PubMed
    1. Emini E A, Jameson B A, Lewis A J, Larsen G R, Wimmer E. Poliovirus neutralizing epitopes: analysis and location with neutralizing monoclonal antibodies. J Virol. 1982;43:997–1005. - PMC - PubMed
    1. Fricks C E, Icenogle J P, Hogle J M. Trypsin sensitivity of the Sabin strain of type 1 poliovirus: cleavage sites in virions and related particles. J Virol. 1985;54:856–859. - PMC - PubMed

Publication types

LinkOut - more resources